Eswar Krishnan

10.3k citations
115 papers · 7.8k · 1 hit paper · h-index 50

Impact in

  • Nephrology top 0.1%
    • Gout, Hyperuricemia, Uric Acid
  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments

Papers in

    • Gout, Hyperuricemia, Uric Acid 40
    • Rheumatoid Arthritis Research and Therapies 17
    • Systemic Lupus Erythematosus Research 6

Eswar Krishnan

112 papers receiving 7.4k citations

Eswar Krishnan's Hit Papers

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 2019 · 216 citations
2160+2+4Years since publication50100150200

Peers

Eswar Krishnan
Comparison fields: 5 of 161
  • Nephrology 2.9k
  • Rheumatology 2.1k
  • Pathology and Forensic Medicine 824
  • Immunology 725
  • Surgery 990
Replace Elizabeth W. Karlson with:
Elizabeth W. Karlson United States
Joshua F. Baker United States
Gere Sunder–Plassmann Austria
Matthew J. Grainge United Kingdom
Yon Su Kim South Korea
Rainer Oberbauer Austria
Rubén Burgos‐Vargas Mexico
Michael J. Pencina United States
Fabio Pellegrini Italy
Jaap Fransen Netherlands
Eswar Krishnan relative to Elizabeth W. Karlson United States Elizabeth W. Karlson's profile →
Citations per field
00.5×1.5×1.8×
Elizabeth W. Karlson · 1×
Citations per year

Countries citing papers authored by Eswar Krishnan

Since Specialization
Citations

This map shows the geographic impact of Eswar Krishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eswar Krishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eswar Krishnan more than expected).

Fields of papers citing papers by Eswar Krishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eswar Krishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eswar Krishnan. The network helps show where Eswar Krishnan may publish in the future.

Co-authors

The 25 scholars most cited alongside Eswar Krishnan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eswar Krishnan Line = papers co-authored together Eswar Krishnan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 115 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2006351
2 2012299
3 2005287
4 2008270
5 2006231
6 2012217
7
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial
Hit paper breakdown →
2019216
8 2006204
9 2009203
10 2004173
11 2010165
12 2013159
13 2018158
14 2008152
15 2011150
16 2007144
17 2011134
18 2013132
19 2003127
20 2012119

About Eswar Krishnan

Eswar Krishnan is a scholar working on Nephrology, Rheumatology, Pathology and Forensic Medicine, Immunology and Surgery, having authored 115 papers that have together received 7.8k indexed citations. Recurring topics across this work include Gout, Hyperuricemia, Uric Acid (40 papers), Rheumatoid Arthritis Research and Therapies (17 papers), Biosimilars and Bioanalytical Methods (8 papers), Systemic Lupus Erythematosus Research (6 papers), Liver Disease Diagnosis and Treatment (6 papers), Systemic Sclerosis and Related Diseases (6 papers), Alcohol Consumption and Health Effects (5 papers) and Pharmaceutical studies and practices (5 papers). The work is most often cited by research in Nephrology (2.9k citations), Rheumatology (2.1k citations), Pathology and Forensic Medicine (824 citations), Immunology (725 citations) and Surgery (990 citations). Eswar Krishnan has collaborated with scholars based in United States, Finland and Netherlands. Frequent co-authors include James F. Fries, H. Ralph Schumacher, Joshua F. Baker, C. Kent Kwoh, Tuulikki Sokka, Matthias Rose, Bonnie Bruce, Eliza F. Chakravarty, Bharathi Lingala and Pekka Hannonen. Their work appears in journals such as Arthritis Research & Therapy, Annals of the Rheumatic Diseases, The Journal of Rheumatology, Lara D. Veeken and The American Journal of Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact